Skip to Content

Nystatin / triamcinolone topical Pregnancy and Breastfeeding Warnings

Nystatin / triamcinolone topical is also known as: Mycasone, Myco Biotic II, Myco-Triacet II, Mycogen II, Mycolog II, Mycomar, Mytrex, NTA, Nyst-Olone II, Tri-Statin II

Medically reviewed on Dec 3, 2018

Nystatin / triamcinolone topical Pregnancy Warnings

Nystatin-triamcinolone topical has been assigned to pregnancy category C by the FDA. In animal studies, low doses of systemic corticosteroids have had teratogenic effects and more potent corticosteroids have been teratogenic after dermal application. There are no controlled data in human pregnancy. Nystatin-triamcinolone is only recommended for use in pregnancy when benefit outweighs risk and should not be used on pregnant patients for extended periods of time or in large amounts.

See references

Nystatin / triamcinolone topical Breastfeeding Warnings

There are no data on the excretion of nystatin-triamcinolone topical into human milk. The manufacturer recommends that caution be used when administering this drug to nursing women.

See references

References for pregnancy information

  1. "Product Information. Mycolog II (nystatin-triamcinolone topical)" Apothecon Inc, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Mycolog II (nystatin-triamcinolone topical)" Apothecon Inc, Princeton, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide